165 related articles for article (PubMed ID: 8051830)
21. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
23. [Miniglucagon: is the precursor a traitor to its family or a genius? ].
Bataille D; Fontés G; Costes S; Longuet C; Dalle S
Journ Annu Diabetol Hotel Dieu; 2004; ():139-49. PubMed ID: 15259312
[No Abstract] [Full Text] [Related]
24. A new Alzheimer's disease interventive strategy: GLP-1.
Perry TA; Greig NH
Curr Drug Targets; 2004 Aug; 5(6):565-71. PubMed ID: 15270203
[TBL] [Abstract][Full Text] [Related]
25. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
Gromada J; Rorsman P
Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
[TBL] [Abstract][Full Text] [Related]
26. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.
MacDonald PE; El-Kholy W; Riedel MJ; Salapatek AM; Light PE; Wheeler MB
Diabetes; 2002 Dec; 51 Suppl 3():S434-42. PubMed ID: 12475787
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting beta TC3 cells.
Gromada J; Rorsman P
Acta Physiol Scand; 1996 Jul; 157(3):349-51. PubMed ID: 8830891
[No Abstract] [Full Text] [Related]
28. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
Vahl T; D'Alessio D
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
[TBL] [Abstract][Full Text] [Related]
29. The incretins--outdated terminology in man?
Edwards CM; Bloom SR
Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
[No Abstract] [Full Text] [Related]
30. The incretin notion and its relevance to diabetes.
Habener JF
Endocrinol Metab Clin North Am; 1993 Dec; 22(4):775-94. PubMed ID: 8125072
[TBL] [Abstract][Full Text] [Related]
31. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
32. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
Fridolf T; Böttcher G; Sundler F; Ahrén B
Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
[TBL] [Abstract][Full Text] [Related]
33. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.
Byrne MM; Göke B
Diabet Med; 1996 Oct; 13(10):854-60. PubMed ID: 8911778
[TBL] [Abstract][Full Text] [Related]
34. Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors.
Holst JJ
Adv Exp Med Biol; 2003; 524():263-79. PubMed ID: 12675249
[TBL] [Abstract][Full Text] [Related]
35. Learning from the gut.
Mattson MP; Perry T; Greig NH
Nat Med; 2003 Sep; 9(9):1113-5. PubMed ID: 12949521
[No Abstract] [Full Text] [Related]
36. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
Gromada J; Holst JJ; Rorsman P
Pflugers Arch; 1998 Apr; 435(5):583-94. PubMed ID: 9479010
[TBL] [Abstract][Full Text] [Related]
37. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
Baggio LL; Drucker DJ
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 is a physiological incretin in rat.
Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes.
Nauck M
Diabet Med; 1996 Sep; 13(9 Suppl 5):S39-43. PubMed ID: 8894470
[TBL] [Abstract][Full Text] [Related]
40. Incretin hormones--an update.
Holst JJ; Orskov C
Scand J Clin Lab Invest Suppl; 2001; 234():75-85. PubMed ID: 11713984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
